Novel racemosin B derivatives as new therapeutic agents for aggressive breast cancer
- 1 December 2018
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 26 (23-24) , 6096-6104
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Carbazole derivatives: a promising scenario for breast cancer treatmentMini-Reviews in Medicinal Chemistry, 2016
- Carbazole Scaffold in Medicinal Chemistry and Natural Products: A Review from 2010-2015Current Topics in Medicinal Chemistry, 2016
- Recent Developments and Biological Activities of N-Substituted Carbazole Derivatives: A ReviewMolecules, 2015
- Heterocyclic scaffolds as promising anticancer agents against tumours of the central nervous system: Exploring the scope of indole and carbazole derivativesEuropean Journal of Medicinal Chemistry, 2015
- Biological potential of carbazole derivativesEuropean Journal of Medicinal Chemistry, 2015
- Racemosins A and B, two novel bisindole alkaloids from the green alga Caulerpa racemosaFitoterapia, 2013
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012European Journal of Cancer, 2013
- Occurrence, Biogenesis, and Synthesis of Biologically Active Carbazole AlkaloidsChemical Reviews, 2012
- Unusual Sulfamate Indoles and a Novel Indolo[3,2-a]carbazole from Ancorina sp.1The Journal of Organic Chemistry, 2002
- Molecular portraits of human breast tumoursNature, 2000